ACR/ARHP Annual Meeting 2015
Is Non-TNF Targeted Tx Better Than a Second Anti-TNF Drug?
A non-TNF-targeted biologic showed better efficacy than a second anti-TNF agent for patients with rheumatoid arthritis and insufficient response to TNF-inhibitors, according to research presented at the 2015 ACR/ARHP Annual Meeting.
